Bruker Corporation announced the formation of a new division, Bruker Spatial Biology, on September 20, 2024. This division consolidates NanoString Technologies, Canopy Biosciences, and Bruker Spatial Genomics, Inc., aiming to provide diverse and comprehensive solutions for spatial biology.
The new division will focus on advancing biomedical research with a suite of spatial biology instruments, assays, software, data analytics, and contract research organization (CRO) services. Its portfolio includes NanoString’s GeoMx, CosMx, and AtoMx platforms, along with Canopy Biosciences’ CellScape, and NanoString’s nCounter for gene expression analysis.
This strategic move positions Bruker with a comprehensive spatial technology offering designed to address distinct spatial biology research needs. The coordination of these platforms is expected to elevate Bruker's capabilities across spatial genomics, transcriptomics, and proteomics.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.